The company’s upstream and downstream process development departments have accumulated years of technical expertise and now have a mature protein expression and technology platform, a mature protein purification preparation platform, and a mature protein structure-function mechanism research platform. We are committed to optimizing production processes, improving product quality, and researching protein activity and yield. We use materials and techniques suitable for large-scale production, and provide stable downstream processes and quality research and documentation systems for drug process development. Our products and services include monoclonal antibodies, recombinant proteins, fusion proteins, cytokines, and growth factor protein drugs for purification and services. Specific areas of focus include but are not limited to:
- Development of different host expression platform technologies;
- Development and optimization of chromatographic purification processes (affinity chromatography, ion exchange chromatography, hydrophobic chromatography, mixed mode chromatography);
- Protein CMC quality evaluation systems that meet the requirements of biological raw materials and stable protein products with output activity and purity;
- Continuous flow process development;
- Technology transfer at pilot and 100L scale;
- Risk assessment of purification process unit operations;
- Protein activity analysis and quality platform capabilities that meet GMP requirements.